Guardian Pharmacy Services, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: To elect Class II directors, to hold office until the annual meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified: John Ackerman

Guardian Pharmacy Services, Inc.’s own tally for this item (“Elect Director: John Ackerman”): 44,674,937 for, 9,584,243 withheld, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Class II Directors The stockholders of the Company elected to the Company's Board of Directors each of the Class II director nominees named below, to hold office until the Company's annual meeting of stockholders to be held in 2029 and until their respective successors are …”
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 79 asset managers below reported 2,865,895 for, 4,770,114 withheld, 16 abstained.

Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.

Description as filed by funds: To elect Class II directors, to hold office until the annual meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified: Randall Lewis

Guardian Pharmacy Services, Inc.’s own tally for this item (“Elect Director: Randall Lewis”): 44,821,861 for, 9,437,319 withheld, per its Form 8-K filed May 7, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Class II Directors The stockholders of the Company elected to the Company's Board of Directors each of the Class II director nominees named below, to hold office until the Company's annual meeting of stockholders to be held in 2029 and until their respective successors are …”
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 79 asset managers below reported 2,901,582 for, 4,734,427 withheld, 16 abstained.

Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.

Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.

Guardian Pharmacy Services, Inc.’s own tally for this item (“2. Approval, on a Non-Binding Advisory Basis, of the Compensation of the Company's Named Executive Officers”): 53,758,195 for, 500,207 against — passed, per its Form 8-K filed May 7, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Approval, on a Non-Binding Advisory Basis, of the Compensation of the Company's Named Executive Officers The stockholders of the Company approved, on a non-binding advisory basis, the compensation of the Company's named executive officers as described in the proxy statement for the Ann…”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 78 managers: 7,635,657 for, 88 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 142 managers: 13,062,901 for, 112,774 against, 91 abstained, 5,277 1 year. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To approve, on a non-binding advisory basis, the frequency of the Company's future advisory votes to approve the compensation of the Company's named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 76 managers: 97,340 for, 7,471,513 1 year, 22,656 unknown, 17,876 3 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 136 managers: 948,600 for, 100 against, 10,745,611 1 year, 26,895 3 year. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026.

Guardian Pharmacy Services, Inc.’s own tally for this item (“4. Ratification of Appointment of Independent Registered Public Accounting Firm”): 55,073,124 for, 91,887 against — passed, per its Form 8-K filed May 7, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 – Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 79 asset managers below reported 7,636,025 for.

Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.